Loading…
Alpha Tau Medical Ltd. is projected to rise to $12.57 by 2027, a +22% move from its current price of $10.29. DRTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.85 | $10.28 | $10.74 | -0.06% |
| May 30 | $9.66 | $10.28 | $10.93 | -0.12% |
| May 31 | $9.52 | $10.27 | $11.08 | -0.18% |
| Jun 1 | $9.41 | $10.27 | $11.20 | -0.24% |
| Jun 2 | $9.31 | $10.26 | $11.31 | -0.30% |
| Jun 3 | $9.21 | $10.25 | $11.41 | -0.36% |
| Jun 4 | $9.13 | $10.25 | $11.50 | -0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.13 | $10.25 | $11.50 | -0.42% |
| Week 2 | $8.67 | $10.20 | $12.01 | -0.84% |
| Week 3 | $8.32 | $10.16 | $12.41 | -1.26% |
| Week 4 | $8.03 | $10.12 | $12.74 | -1.68% |
| Week 5 | $7.78 | $10.07 | $13.04 | -2.09% |
| Week 6 | $7.56 | $10.03 | $13.31 | -2.51% |
| Week 7 | $7.36 | $9.99 | $13.56 | -2.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha-DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
The company is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd. trades under the symbol DRTS. The current price is $10.04 and the market cap stands at $906.87M. The company is ranked 2604 by market capitalization.
A major floor 44.5% below — a decisive break under it would weaken the trend.
The nearest floor, 29.1% below — buyers have tended to step in here.
The nearest ceiling, 8.6% above — a clean break opens room to run.
A major ceiling 30.9% above — clearing it would confirm fresh momentum.
Key DRTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.57 | Sell | $10.38 | Sell |
| MA 10 | $10.40 | Sell | $10.19 | Buy |
| MA 20 | $9.37 | Buy | $9.61 | Buy |
| MA 50 | $8.19 | Buy | $8.57 | Buy |
| MA 100 | $7.62 | Buy | $7.59 | Buy |
| MA 200 | $5.82 | Buy | $6.33 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.45 | Neutral |
| Stoch RSI (14) | 33.07 | Neutral |
| CCI (20) | 52.26 | Neutral |
| Williams %R (14) | -26.73 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 20.92 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 73.27 | Neutral |
| TRIX (15) | 1.24 | Buy |
| Awesome (5,34) | 1.84 | Buy |
| Ultimate (7,14,28) | 56.07 | Neutral |
| Momentum (10) | 0.41 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 10.36 | Sell |
| ADX (14) | 23.92 | Buy |
| ATR (14) | 0.41 | Info |
The near-term technical picture is bullish, with RSI14 at 60. The stock trades above both key moving averages, with SMA50 at $8.07 and SMA200 at $5.75, suggesting constructive momentum. Support is $7.30 and resistance is $11.18, framing a near-term range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.83 | $10.29 | $15.38 | 0% | Neutral | |
| $9.39 | $12.57 | $18.11 | +22% | Bullish | |
| $9.86 | $13.82 | $20.98 | +34% | Bullish | |
| $10.99 | $16.04 | $25.36 | +56% | Bullish | |
| $14.96 | $22.61 | $36.99 | +120% | Bullish | |
| $17.97 | $28.08 | $47.34 | +173% | Bullish | |
| $19.52 | $31.46 | $54.45 | +206% | Bullish | |
| $22.06 | $36.64 | $64.95 | +256% | Bullish | |
| $21.06 | $36.01 | $65.23 | +250% | Bullish | |
| $21.69 | $38.13 | $70.48 | +271% | Bullish | |
| $33.62 | $67.44 | $135.50 | +555% | Bullish | |
| $68.80 | $152.89 | $345.85 | +13.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.83 | $10.29 | $12.20 | +0.00% |
| June 2026 | $8.52 | $10.13 | $12.44 | -1.53% |
| July 2026 | $8.07 | $9.74 | $12.21 | -3.89% |
| August 2026 | $8.30 | $10.12 | $12.89 | +3.95% |
| September 2026 | $8.69 | $10.69 | $13.80 | +5.64% |
| October 2026 | $8.61 | $10.67 | $13.93 | -0.20% |
| November 2026 | $8.66 | $10.82 | $14.27 | +1.35% |
| December 2026 | $9.18 | $11.55 | $15.38 | +6.75% |
Click any year to see its month-by-month DRTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, DRTS could reach as high as $15.38, with a base case around $10.29 and support toward $4.83 — roughly 0% from $10.29. Price action looks broadly range-bound.
Expect DRTS to range from $9.39 to $18.11 through 2027. The $12.57 average target implies a +22% move from current prices. That is up +22% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The DRTS price prediction for 2028 points to an average of $13.82 (low $9.86, high $20.98) — a potential gain of +34% on today's $10.29. Momentum favours further upside here.
In 2029, DRTS is projected to trade between $10.99 and $25.36, averaging $16.04 — a potential gain of +56% from today's $10.29. That is up +16% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Alpha Tau Medical Ltd.'s 2030 outlook centres on $22.61, within a $14.96 to $36.99 range. That is up +41% on the projected 2029 average. That marks a +120% change versus current levels. Momentum favours further upside here.
By 2031, DRTS could reach as high as $47.34, with a base case around $28.08 and support toward $17.97 — roughly +173% from $10.29. Buyers look set to stay in control over this stretch.
Expect DRTS to range from $19.52 to $54.45 through 2032. The $31.46 average target implies a +206% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The DRTS price prediction for 2033 points to an average of $36.64 (low $22.06, high $64.95) — a potential gain of +256% on today's $10.29. Buyers look set to stay in control over this stretch.
In 2034, DRTS is projected to trade between $21.06 and $65.23, averaging $36.01 — a potential gain of +250% from today's $10.29. That is -2% versus the projected 2033 average. Momentum favours further upside here.
Alpha Tau Medical Ltd.'s 2035 outlook centres on $38.13, within a $21.69 to $70.48 range. That is up +6% on the projected 2034 average. That marks a +271% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, DRTS could reach as high as $135.50, with a base case around $67.44 and support toward $33.62 — roughly +555% from $10.29. Momentum favours further upside here.
Expect DRTS to range from $68.80 to $345.85 through 2050. The $152.89 average target implies a +13.9x move from current prices. That is up +127% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DRTS today (≈ 97.18173 DRTS) could be worth
$14,858.19
+$13,858.19 (+1386%) by 2050 · US Dollar
Based on the average projected DRTS price of $152.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRTSwould be worth at today's price.
$1,000 invested in DRTS on May 27, 2025 (≈ 325.732906 DRTS) would be worth
$3,351.79
+$2,351.79 (+235.2%) today · 3.35× · US Dollar
Based on a DRTS entry price of $3.07 vs. today's $10.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.18 | $920.39 | -8.0% |
| 1 month ago | $7.91 | $1,300.88 | +30.1% |
| 3 months ago | $7.93 | $1,297.6 | +29.8% |
| 6 months ago | $3.97 | $2,591.94 | +159.2% |
| 1 year ago | $3.07 | $3,351.79 | +235.2% |
| All time (5.0y) ago | $9.68 | $1,063.02 | +6.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRTS forecast.
Our base-case forecast reaches $21.00 around 2030.
Implied market cap at $21.00: $1.9B
The multi-year forecast shows a clear bullish trajectory from 2027 onward. The 2026 forecast shows min $4.83, avg $10.04, max $15.28 with ROI 0% and sentiment Neutral. By 2030 the avg price is $22.72 with ROI 126.3% and sentiment Bullish, and by 2040 the avg price is $68.00 with ROI 577.3% and sentiment Bullish.
The 2050 forecast projects avg $159.28 with ROI 1486.5% and sentiment Bullish, with a max of $366.35 and a min of $71.68. Across years, the forecast progresses from neutral in 2026 to bullish thereafter, implying substantial upside potential though these are estimates, not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $14.77, avg $22.72, max $37.76; ROI 126.3%; sentiment Bullish.
Forecasts show bullish sentiment from 2027 onward, with average prices rising from $12.10 in 2027 to $159.28 by 2050 and ROIs up to 1486.5%, though 2026 is Neutral and these are estimates, not guarantees.
Yes. The 2040 forecast lists a max of $139.67 and an average of $68.00, indicating the potential to exceed $100 within that horizon.
Current price is $10.04 and market cap is $906.87M.
The 30-day range is $7.42 to $13.59, with support at $7.30 and resistance at $11.18 and a bullish longer-term stance.
Alpha Tau Medical Ltd. Community Discussion
0Share your Alpha Tau Medical Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.